Testosterone Gel Reviews: Does Gel Actually Work, and Why Do the Ratings Disagree?

Editorial research. Not clinically reviewed. Educational information, not medical advice.

---

Testosterone gel reviews are split down the middle, and there's a real reason for it. In the FDA registration trials, 74% to 82% of men reached a normal testosterone range once the dose was adjusted properly. In a large 2009 U.S. medical-claims cohort of topical testosterone users, only 15.4% met the study's persistence definition at twelve months. Both numbers are true. They're just answering different questions.

That gap is the whole story, and almost nobody writing about gel explains it.

The answer changes if your blood was drawn on the wrong schedule for your specific product, if you're applying it somewhere its label doesn't approve, if your dose was never raised past the starting dose, if you want children in the next few years, or if you have small kids at home and won't reliably keep the site covered.

Gel may be worth a real trial if you: want steady daily levels instead of injection peaks and troughs, dislike needles, can commit to the same 60 seconds every morning, and can cover the application site and wash before skin contact.

Gel may be the wrong starting point if you: are trying to conceive in the near term, shower or swim soon after getting dressed, share constant skin contact with young children, know you'll skip days, or haven't yet had two separate early-morning testosterone tests.

TRT Provider Guide is the independent decision resource for testosterone replacement therapy — helping U.S. adults understand how low testosterone is evaluated, compare online and local care models and providers, and choose the next step that fits their health needs, fertility plans, budget, state, and care preferences, with every material claim verified and dated.

This page is educational information, not medical advice. Testosterone is a Schedule III controlled substance in the United States and requires a valid prescription. Don't start, stop, or change a dose on your own. For chest pain, sudden shortness of breath, or new pain and swelling in one leg, get urgent medical care now.

---

Why do testosterone gel reviews disagree so much?

Consumer ratings for testosterone gel run from about 6.3 out of 10 to about 7.4 out of 10 depending on which product you look at, and one major platform shows 3.4 out of 5 — but that lower score pools five different medicines, including a skin patch, into one average. Several of the products being reviewed are also no longer sold in the U.S. Before you weigh anyone's review, check whether it's about your product, your strength, and this decade.

We pulled the actual numbers on September 18, 2026. Here's what they look like side by side, which is something the review sites themselves don't show you.

What the rating platforms actually say

Read September 18, 2026. Review counts and averages change continuously. These are other companies' user ratings. We don't rate medicines, and we don't publish star scores of our own.

Now look at what's wrong with that picture.

Testim's lower user rating cannot be read as a clean effectiveness score. Its reviews repeatedly mention smell and stickiness alongside comments about response. Testim's FDA label says the product may have an alcoholic or musk odor and lists pentadecalactone among its inactive ingredients. That makes the review score a mix of treatment experience and product feel, not a measure of clinical efficacy.

One platform's average isn't about gel at all. WebMD's 3.4 out of 5 covers Androderm, a testosterone patch, alongside the gels. Patches have a very different skin-reaction profile. A patch complaint lowers a gel's rating.

Some reviews are for medicines you can't buy. Endo notified the FDA in a letter dated December 1, 2023 that it was discontinuing brand Fortesta, and the FDA moved it to the Orange Book's Discontinued Drug Product List. A Federal Register notice on November 20, 2024 confirmed it was not pulled for safety or effectiveness reasons — it simply stopped being sold. Its 27 reviews still sit in the averages.

A 2025 packaging recall is another reason to check the exact product before treating reviews as universal. Teva initiated a nationwide recall on November 7, 2025 for one lot of testosterone gel 1% in 2.5 g unit-dose packets — Lot #100068692, expiring April 30, 2027. The affected packets could leak because of a side-seal defect, creating a risk of underdosing. The recall was classified Class III in December 2025 (recall D-0198-2026). That fact does not explain unrelated negative reviews, but it does matter if your prescription matches the recalled NDC and lot.

None of this means reviews are worthless. It means you have to read them for the right thing. Reviews are excellent at telling you what a medicine is like to live with. They are poor at telling you whether it will work in your body. Those are separate questions, and the rest of this page separates them.

---

Does testosterone gel actually work?

Yes, for most men in the trials. In the FDA registration studies, 81.6% of men on AndroGel 1.62% had an average testosterone level inside the normal range by day 112, and 78% were still there at day 364. A thigh-applied 2% gel reached 77.5% by day 90, and a 1% gel reached 74% by day 90. Those trials all titrated the dose — meaning the dose was adjusted based on blood results rather than left where it started.

Here's where it gets interesting. Four different sources measure testosterone gel, and they produce four different-looking answers.

The four numbers, and what each one is actually measuring

One caution on those first percentages, because it matters: 81.6%, 77.5% and 74% came from separate product-development studies with different designs, different populations, and different day counts. They are not a head-to-head comparison. Lining them up to crown a winner would be wrong, and you'll see pages do exactly that.

The part we'd rather not lead with

Only 15.4% of men in that 2009 claims cohort met the study's definition of persistence at one year. That figure comes from a retrospective analysis of medical claims and reflects a historical patient population, not the men starting gel today — but it's the most honest number on this page, and we're not going to bury it.

Here's what it is not. It is not evidence that the molecule fails. The same drug put roughly four out of five trial participants into a normal range and kept 78% there for a full year.

It's friction. Daily application. Washing rules. A pump you have to remember before your shirt goes on. Insurance paperwork. A dose ladder nobody climbed. And a follow-up blood test that, as you're about to see, is very easy to time wrong.

Some of that friction is fixable. Some of it is a sign that gel is simply a poor fit for the person using it. That's why the next section focuses on the checks that can be verified before anyone concludes the treatment format itself failed.

One thing worth settling before you read further. A single low testosterone result is not a diagnosis. Current urology guidance uses a total testosterone level below 300 ng/dL as a reasonable cut-off, confirmed on two separate early-morning tests, combined with matching symptoms or signs. The Endocrine Society frames it the same way — symptoms plus consistently low levels, measured properly. If that hasn't happened yet, no review on the internet can tell you whether gel is right for you, because the question hasn't been asked correctly yet.

Haven't had two early-morning tests yet? That's the step that comes before choosing any treatment format. 👉 Map your situation with TRT Provider Guide's Find My TRT Path tool — free, and it tells you which care route fits and what to ask before you pay anyone.

Find My TRT Path is educational and non-diagnostic. It does not confirm low testosterone, determine medical eligibility, or guarantee a prescription.

The right TRT provider is not the same for every person — it depends on whether low testosterone has been properly evaluated, your symptoms and health history, your fertility plans, your state, your insurance or cash-pay preference, your treatment-format preference, your budget, and whether online or in-person care is the better starting point. Some situations belong with primary care, urology, endocrinology, reproductive urology, or urgent or emergency care when the symptoms warrant it. Because a general answer cannot resolve those for you, use TRT Provider Guide's Find My TRT Path tool to map your situation to the right care route and the questions to ask before you pay.

---

Why isn't my testosterone gel working?

Before you conclude that gel failed you, five things are worth checking with your prescriber: whether your blood was drawn on the schedule your specific product's label uses, whether you're applying it where that label approves, whether your dose was ever raised past the starting dose, whether you shower or swim too soon after applying, and whether your packets came from a recalled lot. In the AndroGel 1.62% pivotal trial, 81% of men finished on a dose other than the one they started on.

This is the section for the man who has been at it ten weeks, feels about the same, and just got a follow-up number that underwhelmed him.

Check 1: Was your blood drawn on the right schedule for your product?

This is easy to overlook, and the labels do not all use the same monitoring schedule.

Different gels are measured at completely different moments. Not "roughly the same." Completely different.

Read that again. One product's dose ladder is built on a level taken before you apply anything. Another is built on a level taken two hours after. Draw the same man's blood at both moments on the same day and you get two very different numbers.

The question worth asking out loud at your next appointment: "Was my level drawn on the schedule my specific product's label uses?"

Don't change anything yourself based on the answer. Just ask. It costs nothing and it's the highest-value question on this page.

Check 2: Are you applying it where the label says?

Two products with almost the same name have different approved application areas. AndroGel 1% is labeled for shoulders, upper arms, or the abdomen. AndroGel 1.62% is labeled for shoulders and upper arms only — its label specifically rules out the abdomen, genitals, chest, armpits and knees. Fortesta goes on the front and inner thighs and nowhere else.

Every one of these labels carries a version of the same warning: application site and dose are not substitutable between topical testosterone products. A friend's routine is not your instructions.

Check 3: Are you still on the starting dose?

Here's a number we worked out from the AndroGel 1.62% label's own clinical trial table, because as far as we can tell nobody has published it.

Every man in that pivotal trial started at 40.5 mg — two pumps. At day 112, after titration, the final doses broke down like this: 12 men on 20.25 mg, 34 on 40.5 mg, 54 on 60.75 mg, and 79 on 81 mg. That's 179 men.

Only 34 of them — 19% — finished where they started. 81% needed a different dose. More than four out of ten ended up on the maximum.

For AndroGel 1.62%, the label's titration table uses a pre-dose morning result: above 750 ng/dL calls for a one-step decrease, 350 to 750 calls for no change, and below 350 calls for a one-step increase. Those are product-label titration criteria, not targets to use on your own. If a result fell into an adjustment range, ask your prescriber whether the label-based titration plan was followed.

Check 4: When do you shower?

The AndroGel 1.62% label reports a study on exactly this. Men who showered two hours after applying lost about 13% of their average testosterone exposure. At six hours, about 12%. At ten hours, showering had no measurable effect at all.

And AndroGel 1% is stricter than its sibling — its label calls for waiting five hours before washing the site or swimming, where the 1.62% product says two.

If you apply gel and shower forty minutes later, that is outside the labeled waiting interval for the topical products compared here and may reduce exposure. That is worth correcting with your prescriber before labeling the medicine ineffective.

Two smaller findings from the same label, since they surprise people: applying moisturizing lotion over the site an hour later increased average exposure by about 14%, and sunscreen increased it by about 8%. Don't use that as a hack — dose changes belong with your clinician — but it does show how much the routine moves the number.

Check 5: Could it be the packaging?

If you use 1% gel in 2.5 g packets and something changed suddenly, ask your pharmacist whether your lot was part of the November 2025 leaking-seal recall described earlier. It's a five-second question.

And if all five check out?

If those practical checks are all addressed and the response is still inadequate, the next conversation is about whether the specific product or treatment format fits — not about changing anything on your own.

There's real evidence that switching brands can help. In a retrospective review of 370 men on gel at a single clinic, 75 of them — 20% — were switched to the other brand after a poor response. Among men moved from AndroGel to Testim, mean total testosterone rose from 311 ng/dL to 484 ng/dL; before the switch, 58% of them were sitting below 300 ng/dL. The reverse switch, Testim to AndroGel, showed no significant change.

That's a 2008 chart review from one clinic, not a randomized trial, and it doesn't mean brand-swapping fixes everyone. But it does mean "gels don't work for me" may really be "that gel didn't work for me" — and that's worth knowing before you abandon the format.

Not sure whether your follow-up testing was done right? The timing, the number of tests, and what gets measured are the things most worth confirming before you decide anything. 👉 Review what TRT blood tests should actually cover

---

Which testosterone gel is best?

There's no single best gel. They differ in strength, in where the label says to put them, in how long you have to wait before showering, and in how the dose gets adjusted — and none of those differences make one product stronger than another. A higher percentage on the box does not mean a stronger medicine or a dose that suits you.

Label features compared September 2026. This is not dosing guidance. Follow the directions supplied with your exact prescription.

Three things fall out of that table.

The five-hour rule is a lifestyle constraint, not a footnote. If you're on AndroGel 1%, a shower before lunch is inside the window. Men who work out in the morning should know that before they start, not three months in.

Nasal gel exists and behaves differently. Natesto is applied inside the nostrils, one press per side, three times a day. It sidesteps skin transfer entirely, which matters enormously for some households. The trade-off is dosing three times daily instead of once, and levels are checked as early as one month in.

"Gel" is not one product. If somebody hands you a routine that worked for them, check it against your own label first.

---

Can testosterone gel transfer to my wife or my kids?

Yes — and topical testosterone gel labels carry a boxed warning about secondary exposure to testosterone. The risk depends heavily on whether the application and contact precautions are followed. In the manufacturer's own transfer study, a partner who touched an uncovered application site saw her average testosterone rise 280%. When the man wore a t-shirt over the same site, the same contact produced a 6% rise.

We think that comparison is the single most useful fact in the entire prescribing information, and we've never seen a review mention it.

Here's the full set of numbers, all from the labels themselves.

Look at row two and row three together. A t-shirt takes a 280% exposure down to 6%. But using the wrong body area with a t-shirt still produced a 43% rise. The site and the covering both matter, and they matter independently.

What the boxed warning is actually about

Children who were secondarily exposed to testosterone gel have shown enlargement of the penis or clitoris, early pubic hair, increased erections and libido, aggressive behaviour, and advanced bone age. In most reported cases these faded once the exposure stopped. In a few, the genital enlargement did not fully return to normal and bone age stayed modestly advanced. The labels note that in several of those cases, the product's precautions weren't being followed.

Adults aren't exempt. A case report in the Ulster Medical Journal described a woman who developed localised hair growth on the forearm she had used, on and off for about four years, to apply her husband's testosterone gel.

That's not a scare paragraph. It's the reason the precautions exist, and it's why the precautions are not optional.

What the labels tell users to do

Wash your hands with soap and water immediately after applying. Let the gel dry, then cover the site with clothing. Wash the site thoroughly with soap and water before any expected skin-to-skin contact. If someone does touch an unwashed site, wash that area of their skin with soap and water as soon as possible. And tell a clinician about any signs of hormone effects in a child or partner.

One more practical note: these gels are alcohol-based and flammable until dry. Let it dry before you go near a flame.

If your household makes this genuinely hard — a toddler who climbs on you, a pregnant partner, constant skin contact — that's a real reason to discuss a different treatment format before a prescription is written. It's not a failure. It's a fit problem with a solution.

---

What are the real side effects of testosterone gel?

In the 182-day AndroGel 1.62% trial, the most common adverse reaction was a rise in PSA, a prostate blood marker, reported in 11.1% of treated men versus 0% on placebo. Skin reactions at the application site occurred in under 1% of men — far less often than with testosterone patches. Testosterone gel can also raise blood pressure, and it is not recommended if your blood pressure is uncontrolled.

We're showing the placebo column because most articles don't, and without it a percentage means very little.

About 10.7% of men stopped the drug during that period because of an adverse reaction — most of them PSA increases.

Blood pressure deserves its own line

In a 24-hour monitoring study, AndroGel 1.62% raised average blood pressure by about 1.9/1.3 mmHg after 16 weeks. In men already being treated for high blood pressure, the rise was larger — about 3.0/2.2 mmHg. Small on paper, but the label is direct: testosterone gel is not recommended in men with uncontrolled hypertension, and blood pressure should be checked periodically.

What your clinician should be monitoring

Testosterone level, PSA, haemoglobin and haematocrit — haematocrit is the share of your blood made up of red blood cells, and testosterone can push it up — plus liver function, blood lipids, and blood pressure. Anyone telling you a topical lets you skip blood work is wrong.

What happens if you stop

Levels return to roughly where they started within 48 to 72 hours of the last dose. That's worth knowing before a holiday, and it's worth knowing before you decide to quit without telling anyone.

The heart question, answered properly

You'll see two very different takes online, and both are out of date in different ways.

TRAVERSE was the large cardiovascular safety trial the FDA required. It randomised 5,198 men aged 45 to 80 with existing heart disease or multiple risk factors to daily 1.62% testosterone gel or placebo gel, with a mean follow-up of about 33 months. Major cardiac events — cardiovascular death, non-fatal heart attack, non-fatal stroke — occurred in 7.0% of the testosterone group and 7.3% of the placebo group. Hazard ratio 0.96, 95% confidence interval 0.78 to 1.17. It met its non-inferiority test.

That means testosterone didn't exceed placebo's risk by more than the allowed margin, in that population. It does not mean gel protects your heart, and it does not mean there are no risks.

Because the same trial also reported more of these in the testosterone group: non-fatal arrhythmias needing intervention (5.2% vs 3.3%), atrial fibrillation (3.5% vs 2.4%), acute kidney injury (2.3% vs 1.5%), bone fracture (3.5% vs 2.5%), and blood clots in the veins (1.7% vs 1.2%).

Why articles about gel safety go stale fast

Two regulatory moves in eighteen months, and a lot of pages have caught neither.

February 28, 2025: the FDA issued class-wide labeling changes for all testosterone products. TRAVERSE results were added to every label. Cardiovascular language was removed from the Boxed Warning. A blood-pressure warning was added. The limitation about age-related low testosterone stayed.

June 18, 2026: HHS and the FDA requested a further round of changes — removing the limitation of use for age-related hypogonadism, narrowing the prostate cancer contraindication toward metastatic disease, and revising the enlarged-prostate warnings after reviews found no worsening of symptoms in men with mild-to-moderate BPH.

Here's the part that trips people up, and we checked it ourselves: those June 2026 changes were requests, and they don't all appear on labels yet. The AndroGel 1.62% prescribing information we read in September 2026, revised October 2025, still carried the age-related limitation of use. So the official document in the box can be behind the agency's own current position.

Which means one practical thing: don't assume a warning or indication statement has changed in the label supplied with your prescription just because an agency announcement has proposed or requested a change. If coverage turns on age-related indication language, ask the prescriber and insurer which current policy and product label they are using.

Anyone using the 2025 change to tell you testosterone is now "proven safe" or good for your heart is overselling it. Removing one warning did not leave a blank label.

Who needs more than a routine online intake

Known or suspected prostate or breast cancer, elevated hematocrit, untreated severe obstructive sleep apnea, uncontrolled heart failure, a heart attack or stroke within the previous six months, thrombophilia, or suspected pituitary or testicular disease all need direct clinical evaluation. Depending on the issue, primary care, urology, endocrinology, reproductive urology, cardiology, or another specialist may be the right setting. A questionnaire cannot clear those risks.

---

Should I switch from gel to injections?

A switch is worth discussing if the gel has been used as prescribed, product-specific monitoring and titration have been addressed, and the response is still inadequate — or if transfer precautions at home are not realistic. Don't switch because a forum told you gels don't work. In a survey of 382 men, satisfaction was similar across formats: about 68% for gels, 73% for injections and 70% for pellets.

Five honest points:

Gel is not inherently weaker. A percentage on the label is a concentration, not a measure of power.

Skin absorption adds another source of variability. Some men reach the intended range on a topical product after titration; others do not. Injections have different pharmacokinetics and their own practical trade-offs.

Cost can favor injections, but not for everyone. In the 382-man satisfaction survey, lower cost was cited more often by injection users as a reason for their choice. Your actual cost depends on the product, pharmacy, insurance and care model.

Gel has a relatively short washout after the last dose. The AndroGel 1.62% label says serum testosterone returns to approximately baseline within 48 to 72 hours after the final dose. That is a pharmacokinetic fact, not advice to stop treatment on your own.

Fertility risk doesn't change. Testosterone from outside the body suppresses sperm production whether it's a gel, a cream, or a needle. Switching formats doesn't dodge it.

Don't convert an injection dose into a gel amount yourself, or the reverse. The products are absorbed differently and monitored differently. A clinician makes that call and arranges the follow-up.

For the full format breakdown, see our injections vs. gel comparison.

---

Is the "testosterone gel" from online clinics the same thing?

Often, no. Several online programs advertise "topical testosterone" but dispense a compounded testosterone cream, not an FDA-approved gel. A compounded preparation is made by a compounding pharmacy for a prescription under a different regulatory framework; the finished compounded drug is not FDA-approved and has not gone through FDA premarket review as an approved finished drug product. It is a different regulatory category, and the difference should be on the table before you pay.

Disclosure: TRT Provider Guide has commercial relationships with Male Excel, Taurus Meds and Hone Health, and may earn a commission from referrals. That changes nothing about what's on this page, including the part directly below, which tells you our partners are not the answer to this particular question. Read our affiliate disclosure.

Let's be plain about it.

Male Excel's published topical option is a compounded Testosterone Lipoderm Cream. Hone Health's published topical option is a compounded testosterone cream, and its own page says so. Neither is AndroGel. Neither is an FDA-approved gel. Compounding can be entirely lawful and appropriate when a clinician has a reason for it — but nobody should let you believe you're buying the product you searched for when you aren't.

If a specific FDA-approved gel is what you want, a cash-pay cream subscription is the wrong door. The right doors are a clinician who can prescribe the exact product, a pharmacy that stocks it, and — where it applies — your insurance. Some services do name FDA-approved gel products; we've priced and compared them separately.

If you're open to a compounded cream after discussing it with a clinician, that is a different decision from choosing an FDA-approved gel. Some programs bundle clinical follow-up, labs, refills and messaging, but the exact services, pharmacy, price and coverage should be verified before you pay. Make that choice knowingly.

Four questions that settle it in one phone call

1. Is what you'd prescribe me an FDA-approved testosterone gel, or a compounded preparation?
2. What's the exact product name and strength?
3. Which pharmacy fills it, and is it licensed in my state?
4. What does a full year cost — medicine, membership, visits, labs, shipping?

If you get a dodge on question one, that tells you something.

Want an FDA-approved gel specifically? We opened every major service's own pages and checked which ones actually name a gel product, what each publishes as a price, and what's still missing from the quote. 👉 See which providers actually offer testosterone gel and what it really costs

---

What if I want to have children?

Testosterone taken from outside the body can suppress sperm production. This applies to gel exactly as it applies to injections and creams. If children are part of your plan in the next few years, that conversation belongs with a urologist, reproductive urologist, or another fertility-aware clinician before a treatment decision — not after.

The labels are direct about it: with exogenous testosterone, sperm production may be suppressed through feedback on the pituitary gland, and with large doses this can lead to azoospermia — no measurable sperm. The labels also note that for some men, the effect on fertility may be irreversible. Endocrine Society guidance advises against starting testosterone in men planning fertility in the near term.

Here's what we won't tell you: that gel will definitely make you infertile, that fertility can be preserved, or that it returns on any particular timeline. Anyone promising you those things is guessing.

A note on the alternatives you'll see advertised. Clomiphene, enclomiphene and hCG are not TRT and are not interchangeable with it. They work through different mechanisms, their approval status differs, and none of them is "natural testosterone replacement." They belong in a conversation with a specialist who has actually evaluated your fertility, not in a checkout cart.

If near-term fertility is central to your decision, a general TRT checkout should not be the starting point. Discuss the plan with a urologist, reproductive urologist or other fertility-aware clinician before exogenous testosterone; fertility testing, including semen analysis when appropriate, can then be tailored to your situation.

More depth in our TRT and fertility guide.

---

🔎 What we actually verified

Verification date: September 18, 2026

Sources checked: Current FDA prescribing information via DailyMed for AndroGel 1.62%, AndroGel 1% and its generics, Testim, Vogelxo, Fortesta and Natesto; the FDA's February 2025 class-wide labeling statement; the HHS/FDA June 2026 labeling announcement; a Federal Register notice on Fortesta's marketing status; the FDA enforcement record for recall D-0198-2026; AUA and Endocrine Society guidance; peer-reviewed studies on gel switching, patient satisfaction and treatment persistence; and the public rating pages at Drugs.com and WebMD.

Verified facts: Approved application sites and washing intervals for each product; the blood-draw timing each label specifies; dose ranges and the titration ladder; the transfer, handwashing and showering study results; adverse-reaction rates with the placebo comparison; TRAVERSE results as reported in the label; the February 2025 and June 2026 labeling actions; Fortesta's discontinued brand status; and the November 2025 packet recall.

Our own calculation: The finding that 81% of men in the AndroGel 1.62% pivotal trial finished on a dose other than their starting dose is our arithmetic on the dose-distribution table printed in that product's label. The label's numbers are shown above so you can check the maths yourself.

Customer-experience signals, not evidence: The Drugs.com and WebMD ratings and the recurring complaint themes. These describe what people report. They cannot establish that a medicine works, is safe, or will do anything in particular for you.

What we could not confirm: Current retail pharmacy prices in any specific location; whether every generic product listed remains actively marketed in every market this week; and the exact product and dosage form behind one additional testosterone recall listing we found in a secondary database, which is why it isn't mentioned above.

What we did not do: We have not been treated by, purchased from, or held an account with any company named on this page. This is public-source editorial research, not a hands-on review and not a clinical-quality audit.

Our documented method is How We Review TRT Providers.

---

Testosterone gel: common questions

How long does testosterone gel take to work?

Different effects change on different timelines, and the honest answer is that nobody can promise you a date. What the label does specify is when the level gets checked — for AndroGel 1.62%, at about 14 and 28 days after starting or after any dose change. Symptoms are assessed by your clinician over a longer period.

What's the difference between AndroGel 1% and 1.62%?

More than the number. The 1% product is labeled for shoulders, upper arms or the abdomen and calls for waiting five hours before washing the site. The 1.62% product is labeled for shoulders and upper arms only and calls for two hours. Their doses and dose steps are different too, and the labels state they are not substitutable for one another.

Can I put testosterone gel on my stomach?

It depends entirely on the product. AndroGel 1% lists the abdomen as an approved site. AndroGel 1.62% specifically excludes it, as do Testim and Vogelxo. Fortesta is for the front and inner thighs only. Follow the instructions supplied with your exact prescription.

Can I shower after applying testosterone gel?

Yes, after the wait your product specifies — five hours for AndroGel 1%, two hours for AndroGel 1.62%, Testim, Vogelxo and Fortesta. In the manufacturer's study, showering at two hours cost about 13% of average exposure, and showering at ten hours cost nothing measurable.

Is generic testosterone gel as good as the brand?

FDA-approved generics must meet the agency's standards for the product they copy. That is not the same as a compounded cream, which is a different regulatory category. Ask your pharmacist which approved product your prescription will be filled with and whether substitution is allowed.

Why does my testosterone gel smell?

If it's Testim, the label itself notes the product "may have an alcoholic/musk odor," and lists pentadecalactone — a musk compound — among the inactive ingredients. All these gels are alcohol-based, which is also why they're flammable until dry. Odour complaints are about the vehicle, not the testosterone.

Can testosterone gel rub off on my wife or kids?

Yes, and it carries a boxed warning for exactly that reason. In the manufacturer's study, an uncovered site produced a 280% rise in a partner's average testosterone; the same contact with a t-shirt over the site produced a 6% rise. Wash your hands right after applying, let it dry, cover the site, and wash the area before skin-to-skin contact.

Is testosterone gel weaker than injections?

Not inherently. Skin absorption adds a source of variability, while injections have different pharmacokinetics and practical trade-offs. In a survey of 382 men already using TRT, satisfaction was broadly similar — about 68% for gels and 73% for injections.

Does testosterone gel affect fertility?

Yes. Testosterone from outside the body can suppress sperm production, and with large doses this can lead to no measurable sperm. The labels note the effect may be irreversible for some men. Discuss fertility plans with a urologist or reproductive urologist before starting anything.

Is testosterone gel safe for your heart?

In TRAVERSE, a trial of 5,198 higher-risk men, major cardiac events occurred in 7.0% on testosterone gel versus 7.3% on placebo — meeting the trial's non-inferiority test. The same trial reported more atrial fibrillation, blood clots, acute kidney injury and fractures in the testosterone group, and the FDA added a blood-pressure warning in 2025. Non-inferior in one studied group is not the same as safe for everyone.

Is testosterone gel a controlled substance?

Yes. Testosterone is Schedule III in the United States, and that includes topical forms. It requires a valid prescription. Anything sold without one is not a legitimate alternative.

What if my level doesn't come up enough?

That's a clinician's call, not a self-adjustment. Worth raising: whether the blood draw matched your product's schedule, whether the dose was ever titrated, and whether a different product is reasonable to try — one clinic series found that men switched from AndroGel to Testim after a poor response saw mean total testosterone rise from 311 to 484 ng/dL.

Why do some reviews say it did nothing?

Because reviews rarely record the things that decide the outcome: which product, where it was applied, whether the dose was ever raised, and when the blood was drawn. Some also describe products that are no longer sold. Reviews are useful for what a medicine is like to live with, not for whether it will work in you.

---

The bottom line

Testosterone gel is an effective FDA-approved treatment format for appropriately diagnosed men, while a large 2009 claims cohort also found low persistence with topical therapy. Those facts are not in conflict. The trials show roughly three to four men in five reaching the study's target range after titration; the historical claims study found only 15.4% remained persistent at 12 months. Efficacy and long-term use are different questions.

So before you decide the reviews were right about you:

Check the draw timing. Before the dose for most gels; two hours after for the thigh gel. It's the single easiest thing to get wrong.

Check the application site. Two products with nearly the same name have different approved areas.

Check whether your dose ever moved. Four out of five men in the pivotal trial ended up somewhere other than where they started.

Check the shower clock. Two hours for most; five for AndroGel 1%.

Check the household. In the AndroGel 1.62% transfer study, covering the approved application site with a t-shirt reduced the measured partner exposure dramatically compared with direct contact. If your life makes the labeled precautions unrealistic, discuss a different treatment format rather than relying on precautions you cannot consistently follow.

And if reading this made you realise your situation has a fork in it — an unconfirmed diagnosis, fertility plans, a household with small kids, a state question, or a price you can't pin down — don't force the decision from a table.

👉 Still not sure which TRT care route fits you? Use our free Find My TRT Path tool.

---

Last verified: September 2026. Product labeling, marketing status, review platform ratings and regulatory actions were checked on September 18, 2026. Labels are revised without notice, review averages change continuously, and the label supplied with your prescription is the one that applies to you.

Educational information, not medical advice. This page has not been medically reviewed. Testosterone is a Schedule III controlled substance and requires a valid prescription from a licensed clinician. Do not start, stop, switch, or adjust any treatment based on this page.

---

Sources

Accessed September 18, 2026.

• 1. DailyMed — AndroGel 1.62% prescribing information and Medication Guide (revised October 2025): boxed warning, application sites, dose titration table, transfer and showering studies, adverse reactions, blood pressure, TRAVERSE results, clinical studies.
• 2. DailyMed — AndroGel 1% prescribing information: application sites, active NDA status and five-hour washing interval.
• 3. DailyMed — Testim prescribing information: application sites, two-hour interval, inactive ingredients including pentadecalactone.
• 4. DailyMed — Vogelxo prescribing information: application sites, dosing, dermal transfer study.
• 5. FDA — Fortesta prescribing information: thigh application, 10–70 mg range, two-hour post-application blood draw at days 14 and 35, clinical study result.
• 6. Federal Register, November 20, 2024 — Determination that FORTESTA was not withdrawn from sale for reasons of safety or effectiveness (Docket FDA-2024-P-2515).
• 7. California Board of Pharmacy — Teva nationwide recall notice for Testosterone Gel 1%, Lot 100068692, recall initiated November 7, 2025; FDA recall D-0198-2026 was classified Class III in December 2025.
• 8. FDA — FDA issues class-wide labeling changes for testosterone products, February 28, 2025.
• 9. HHS/FDA — HHS announces requested updates to testosterone therapy product labels, June 18, 2026.
• 10. FDA — Testosterone Information.
• 11. American Urological Association — Evaluation and Management of Testosterone Deficiency (published 2018; reviewed and validity confirmed 2024).
• 12. Endocrine Society — Testosterone Therapy for Hypogonadism guideline resources.
• 13. Grober ED, Khera M, Soni SD, Espinoza MG, Lipshultz LI. Efficacy of changing testosterone gel preparations (Androgel or Testim) among suboptimally responsive hypogonadal men. Int J Impot Res. 2008;20:213–217.
• 14. Schoenfeld MJ, Shortridge E, Cui Z, Muram D. Medication adherence and treatment patterns for hypogonadal patients treated with topical testosterone therapy: a retrospective medical claims analysis. J Sex Med. 2013;10:1401–1409.
• 15. Kovac JR et al. Patient satisfaction with testosterone replacement therapies: the reasons behind the choices. J Sex Med.
• 16. McCourt C, Hoey S. An unusual case of localised hypertrichosis. Ulster Med J. 2010;79(2):100.
• 17. Drugs.com — AndroGel user reviews and ratings (read September 18, 2026).
• 18. WebMD — Testosterone topical reviews and ratings (read September 18, 2026).
• 19. DailyMed — Natesto prescribing information: dosing and monitoring.
• 20. DEA — Drug Scheduling: testosterone is a Schedule III controlled substance.